Pilot Study: AI Algorithm for Dermatology Referral Optimization
Launched by AI LABS GROUP S.L · Jan 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new tool that uses artificial intelligence (AI) to help doctors make better referrals to dermatologists for skin conditions. The main goal is to see if this tool can ensure that patients are referred appropriately, which may also help reduce costs, shorten waiting times, and improve how patients are processed in the healthcare system.
To participate in this study, you need to be at least 18 years old and have a skin condition that requires attention. If you decide to join, your doctor will explain the study in detail and answer any questions you have. You'll need to sign a consent form, and then your doctor will take pictures of your skin condition using their smartphone or a special camera. These images and some basic information about you will be stored securely to help the researchers evaluate the effectiveness of the AI tool. Your privacy will be protected throughout the study, following strict regulations.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with skin pathologies.
- • Patients aged 18 years or older.
- • Patients who have signed the informed consent for the study.
- Exclusion Criteria:
- • Patient who at the investigator\'s discretion will not comply with the study procedures.
About Ai Labs Group S.L
ai labs group s.l. is an innovative clinical trial sponsor dedicated to advancing healthcare through the integration of artificial intelligence and data-driven methodologies. With a focus on enhancing the efficiency and reliability of clinical research, the organization collaborates with a diverse range of stakeholders, including pharmaceutical companies, research institutions, and healthcare providers. By leveraging cutting-edge technology and a multidisciplinary approach, ai labs group s.l. aims to streamline clinical trial processes, improve patient outcomes, and accelerate the development of new therapies. Their commitment to ethical research practices and regulatory compliance ensures that all clinical trials meet the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barakaldo, Biscay, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported